These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 33666293

  • 1. Proopiomelanocortin deficiency diagnosed in infancy in two boys and a review of the known cases.
    Graves LE, Khouri JM, Kristidis P, Verge CF.
    J Paediatr Child Health; 2021 Apr; 57(4):484-490. PubMed ID: 33666293
    [Abstract] [Full Text] [Related]

  • 2. Two Cases With an Early Presented Proopiomelanocortin Deficiency-A Long-Term Follow-Up and Systematic Literature Review.
    Gregoric N, Groselj U, Bratina N, Debeljak M, Zerjav Tansek M, Suput Omladic J, Kovac J, Battelino T, Kotnik P, Avbelj Stefanija M.
    Front Endocrinol (Lausanne); 2021 Apr; 12():689387. PubMed ID: 34177811
    [Abstract] [Full Text] [Related]

  • 3. Delayed diagnosis of proopiomelanocortin (POMC) deficiency with type 1 diabetes in a 9-year-old girl and her infant sibling.
    Ozsu E, Bahm A.
    J Pediatr Endocrinol Metab; 2017 Oct 26; 30(10):1137-1140. PubMed ID: 28915118
    [Abstract] [Full Text] [Related]

  • 4. A novel mutation in the proopiomelanocortin (POMC) gene of a Hispanic child: metformin treatment shows a beneficial impact on the body mass index.
    Hilado MA, Randhawa RS.
    J Pediatr Endocrinol Metab; 2018 Jul 26; 31(7):815-819. PubMed ID: 29858905
    [Abstract] [Full Text] [Related]

  • 5. A Patient with Proopiomelanocortin Deficiency: An Increasingly Important Diagnosis to Make.
    Çetinkaya S, Güran T, Kurnaz E, Keskin M, Sağsak E, Savaş Erdeve S, Suntharalingham JP, Buonocore F, Achermann JC, Aycan Z.
    J Clin Res Pediatr Endocrinol; 2018 Mar 01; 10(1):68-73. PubMed ID: 28739551
    [Abstract] [Full Text] [Related]

  • 6. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10.
    Krude H, Biebermann H, Schnabel D, Tansek MZ, Theunissen P, Mullis PE, Grüters A.
    J Clin Endocrinol Metab; 2003 Oct 01; 88(10):4633-40. PubMed ID: 14557433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Late Diagnosis of POMC Deficiency and In Vitro Evidence of Residual Translation From Allele With c.-11C>A Mutation.
    Anisimova AS, Rubtsov PM, Akulich KA, Dmitriev SE, Frolova E, Tiulpakov A.
    J Clin Endocrinol Metab; 2017 Feb 01; 102(2):359-362. PubMed ID: 27906547
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome.
    Krude H, Grüters A.
    Trends Endocrinol Metab; 2000 Feb 01; 11(1):15-22. PubMed ID: 10652501
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
    Clément K, van den Akker E, Argente J, Bahm A, Chung WK, Connors H, De Waele K, Farooqi IS, Gonneau-Lejeune J, Gordon G, Kohlsdorf K, Poitou C, Puder L, Swain J, Stewart M, Yuan G, Wabitsch M, Kühnen P, Setmelanotide POMC and LEPR Phase 3 Trial Investigators.
    Lancet Diabetes Endocrinol; 2020 Dec 01; 8(12):960-970. PubMed ID: 33137293
    [Abstract] [Full Text] [Related]

  • 15. Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist.
    Kühnen P, Clément K, Wiegand S, Blankenstein O, Gottesdiener K, Martini LL, Mai K, Blume-Peytavi U, Grüters A, Krude H.
    N Engl J Med; 2016 Jul 21; 375(3):240-6. PubMed ID: 27468060
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Central dysregulation of the hypothalamic-pituitary-adrenal axis in neuron-specific proopiomelanocortin-deficient mice.
    Smart JL, Tolle V, Otero-Corchon V, Low MJ.
    Endocrinology; 2007 Feb 21; 148(2):647-59. PubMed ID: 17095588
    [Abstract] [Full Text] [Related]

  • 19. Early onset obesity and adrenal insufficiency associated with a homozygous POMC mutation.
    Mendiratta MS, Yang Y, Balazs AE, Willis AS, Eng CM, Karaviti LP, Potocki L.
    Int J Pediatr Endocrinol; 2011 Feb 21; 2011(1):5. PubMed ID: 21860632
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.